Combination product of inhibitor of the SRC family of non-receptor tyrosine kinases and gemcitabine

Details for Australian Patent Application No. 2003279456 (hide)

Owner AstraZeneca AB

Inventors Barge, Alan

Agent Davies Collison Cave

Pub. Number AU-B-2003279456

PCT Number PCT/GB03/04787

PCT Pub. Number WO2004/043472

Priority 0226434.9 13.11.02 GB

Filing date 7 November 2003

Wipo publication date 3 June 2004

Acceptance publication date 17 May 2007

International Classifications

A61K 31/70 (2006.01) - Carbohydrates

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

26 February 2004 Complete Application Filed

  Priority application(s): 0226434.9 13.11.02 GB

8 July 2004 Application Open to Public Inspection

  Published as AU-B-2003279456

17 May 2007 Application Accepted

  Published as AU-B-2003279456

13 September 2007 Standard Patent Sealed

2 June 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003279457-ANALYSIS OF CELL IMAGES

2003279455-FERROMAGNETIC OBJECT DETECTOR